Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

111.55 USD +0.25 (+0.22%)
Streaming Delayed Price Updated: 9:56 AM EST, Jan 19, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Abbott Laboratories

< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Abbott Provides Update on ID NOW™
NYSE: ABT) -- Abbott's ID NOW™ is the fastest molecular point-of-care rapid test available today and has been delivering reliable results when and where they're needed. The availability and... 
From PR Newswire
Absolute to Present at 15th Annual Needham Virtual Technology & Media Conference
Absolute® (ABT.TO), the leader in Endpoint Resilience™, today announced Christy Wyatt, President and Chief Executive Officer, and Leigh Ramsden, Interim Chief Financial Officer, will be presenting at... 
From Business Wire News Releases
Abbott Receives FDA Emergency Use Authorization for COVID-19 Molecular Test on New Alinity™ m System
- Alinity m is Abbott's new molecular lab system, which was approved by the U.S. FDA in March 
From PR Newswire
Absolute Reports Fiscal 2020 Third Quarter Financial Results
Absolute (TSX: ABT) (“Absolute” or the “Company”), the leader in Endpoint Resilience™, today announced its financial results for the three and nine months ended March 31, 2020. All dollar figures are... 
From Business Wire News Releases
Innovative Wearable Devices Offer Patients a New Way to Manage Their Conditions
FinancialBuzz.com News Commentary 
From PR Newswire
Abbott Receives FDA Emergency Use Authorization for COVID-19 Antibody Blood Test on Alinity™ i System
- Data shows reliable results with 99.6% specificity and 100% sensitivity for patients tested 14 days after symptoms began 
From PR Newswire
Research from University of Washington Demonstrates High Performance of Abbott's SARS-CoV-2 Antibody Blood Test
- Researchers found the test to have 99.9% specificity and 100% sensitivity for patients tested 17 days or more after symptoms began 
From PR Newswire
Absolute Empowers Customers to Extend Power of Self-Healing to More Mission-Critical Security Applications
Absolute® (ABT.TO), the leader in Endpoint Resilience™, today announced it is enabling customers to self-heal even more of their mission-critical security controls, recently adding support for... 
From Business Wire News Releases
New Absolute Insights Reveal Increases in Enterprise and Education Device Usage, Vulnerability of Sensitive Data as Endpoints Remain Fragile Amid COVID-19 Outbreak
Absolute (TSX: ABT), the leader in endpoint resilience, today revealed striking insights in the wake of the global COVID-19 outbreak, including a spike in enterprise and education device usage,... 
From Business Wire News Releases
Absolute to Host Conference Call for Fiscal 2020 Third Quarter Financial Results
Absolute (TSX: ABT), the leader in endpoint resilience, today announced it will host a conference call on Monday May 11, at 5:00 p.m. ET (2:00 p.m. PT) to discuss its fiscal 2020 third quarter results.... 
From Business Wire News Releases
AMERICA’S PHARMACIES EXPANDING DIABETIC SHELF SPACE AT RECORD PACE
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
America's Pharmacies Expanding Diabetic Shelf Space at Record Pace
Financialnewsmedia.com News Commentary 
From PR Newswire
Absolute Declares Quarterly Dividend
Absolute (TSX: ABT) today announced that its Board of Directors has declared a quarterly dividend of CAD$0.08 per share on its common shares, payable in cash on May 29, 2020 to shareholders of record... 
From Business Wire News Releases
Thinking about trading options or stock in Abbott Laboratories, Docusign, Microsoft, Netflix, or Tesla?
InvestorsObserver issues critical PriceWatch Alerts for ABT, DOCU, MSFT, NFLX, and TSLA. 
From PR Newswire
Abbott Reports First-Quarter 2020 Results
- First-quarter sales growth of 2.5 percent; organic sales growth of 4.3 percent 
From PR Newswire
Abbott Launches Third COVID-19 Test, a Laboratory-Based Antibody Blood Test That Will Ship in the U.S. Starting Tomorrow
- This adds to Abbott's previously announced COVID-19 molecular tests: the m2000™ lab-based test and ID NOW™ rapid point-of-care test 
From PR Newswire
Abbott Announces Virtual Attendance at Annual Meeting of Shareholders
Abbott (NYSE: ABT) announced today that due to the public health impact of the coronavirus pandemic and to support the health and safety of its shareholders, employees and communities, the company will... 
From PR Newswire
Abbott's TriClip™ Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair
- CE Mark for TriClip represents an important treatment option for people with severe tricuspid regurgitation, a difficult-to-manage heart condition 
From PR Newswire
Abbott's FreeStyle® Libre 14 Day System Now Available in U.S. for Hospitalized Patients with Diabetes During COVID-19 Pandemic
-- More than 50% of people with diabetes who have been diagnosed with COVID-19 are hospitalized, according to a report from the Centers for Disease Control and Prevention (CDC)¹ 
From PR Newswire
Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments
Financialnewsmedia.com News Commentary 
From PR Newswire
Dorset & Wiltshire Fire and Rescue Service Rely on Absolute to Ensure Endpoint Resilience and Privacy of Sensitive Information
To protect their communities, firefighters at Dorset & Wiltshire Fire and Rescue Service (DWFRS) use on-vehicle mobile devices for vital communication and information during incident response and... 
From Business Wire News Releases
Innovative Wearable Tech Gives Doctors a New Approach to Patient Care
FinancialBuzz.com News Commentary 
From PR Newswire
Thinking about trading options or stock in Abbott Laboratories, Autodesk, Amazon.com, Biogen, or Microsoft?
InvestorsObserver issues critical PriceWatch Alerts for ABT, ADSK, AMZN, BIIB, and MSFT. 
From PR Newswire
Abbott Launches Molecular Point-of-Care Test to Detect Novel Coronavirus in as Little as Five Minutes
- The Abbott ID NOW™ COVID-19 test brings rapid testing to the front lines 
From PR Newswire
Absolute Provides Customers with Automated Workflows to Secure and Manage Remote Devices at No Charge In Expanded Response to Global Coronavirus Outbreak
Absolute® (ABT.TO), the leader in endpoint resilience, today announced it is expanding its response to the global coronavirus outbreak, providing all of its customers with access to a comprehensive... 
From Business Wire News Releases
Abbott Hosts Conference Call for First-Quarter Earnings
Abbott (NYSE: ABT) will announce its first-quarter 2020 financial results on Thursday, April 16, 2020, before the market opens. 
From PR Newswire
Abbott Receives FDA Emergency Use Authorization and Launches Test to Detect Novel Coronavirus
- The test will be used on the company's m2000 RealTime system that is currently available in hospitals and molecular laboratories in the U.S. 
From PR Newswire
Advancing Wearable Devices Grant Patients and Doctors Greater Flexibility
FinancialBuzz.com News Commentary 
From PR Newswire
Physicians and Patients Reap the Benefits of Innovative Medical Devices
FinancialBuzz.com News Commentary 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
74 75 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.